Ten of our consultants had four posters accepted and one of our consultants will host an on-demand podium presentation at this year’s virtual Congress.
Price vs. Prevalence series posters:
Exploring The Effect Of Prevalence On Access And Price For Non-Oncology Rare Disease Medicines In England authored by Will Foster, Cecile Matthews & Eva Marchese.
How Does Eligible Patient Number Affect Price in France for NON-Oncology Orphan Drugs? authored by Cecile Matthews, Bhavesh Patel & Owen Male.
How Do RARE Disease Patient Numbers in Germany Affect the Price of NON-Oncology Orphan Drugs? authored by Bhavesh Patel, Cecile Matthews & Owen Male.
OD Designation Trends poster:
Trends in Withdrawal of Orphan Designation for Marketed Products: EU VS. US and JAPAN authored by Ryan Lawlor, Tim Wilsdon, Walter Colasante, Chris Jones & Joan Chen.
OD HTA and Time to Reimbursement podium presentation:
Comparison of Health Technology Assessments and Time to Reimbursement for Orphan Drugs from FOUR HTA Agencies: Opportunities and Challenges in France, Germany, England and Scotland by Ioanna Stefani.
